跳至主要内容
临床试验/2024-517831-28-00
2024-517831-28-00招募中4 期

Monitoring of neuromuscular blockade during general anaesthesia after reversal with neostigmine

Pirkanmaan hyvinvointialue1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年9月17日最近更新:
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
120
试验地点
1
主要终点
To find the incidence of reappearance of nondepolarizing neuromuscular block after reversal with neostigmine

研究概览

简要总结

To find the incidence of reappearance of nondepolarizing neuromuscularblock after reversal with neostigmine.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
接受健康志愿者

入选标准

  • To find the incidence of reappearance of nondepolarizing neuromuscular block after reversal with neostigmine.
  • Body Mass Index (BMI) <35k9/ mz
  • AGE 18-65 years
  • ASA risk class 1-2

排除标准

  • Disease or previous injury of central nervous system
  • Disease or medication affecting peripheral nervous system

结局指标

主要结局

To find the incidence of reappearance of nondepolarizing neuromuscular block after reversal with neostigmine

To find the incidence of reappearance of nondepolarizing neuromuscular block after reversal with neostigmine

次要结局

未报告次要终点

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Maija-Liisa Kalliomäki

Scientific

Pirkanmaan hyvinvointialue

研究点 (1)

Loading locations...

相似试验